Home/Zelluna Immunotherapy/Wolf Hervé Fridman
WH

Wolf Hervé Fridman

Scientific Advisory Board Member

Zelluna Immunotherapy

Therapeutic Areas

Zelluna Immunotherapy Pipeline

DrugIndicationPhase
Proprietary TCR-NK PlatformUndisclosed Solid TumorsPreclinical